n. a carbamate that is a reversible acetylcholinesterase inhibitor, used for the treatment of mild to moderate dementia associated with Alzheimer’s disease (see cognitive enhancer). Because it can cause nausea and loss of appetite, low starting doses with a slow upward titration are recommended. U.S. trade name: Exelon.